Advanced Provision of Care
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- The proportion of participants reporting confidence in key steps of taking medications
研究概览
简要总结
This study aims to evaluate advanced provision of an anti-progestin with a prostaglandin for future use (in the next 12 months) in individuals at risk for pregnancy but not desiring a pregnancy.
详细描述
The purpose of this study is to learn more about counseling via telemedicine and advanced provision of medications to individuals at risk for pregnancy but before they are pregnant. If they experience this event, then they may subsequently have immediate access to the care they need plus an established connection with a health provider.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 40 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •18 to 40 years old at time of consent
- •Anatomically capable of pregnancy
- •Self-reported a history of regular menses (>24 and <38 days) in the past 3 years (other than during pregnancy)
- •Not currently pregnant and not desiring to be pregnant in the next year
- •Say they would seek to end the pregnancy if they became pregnant in the next year and who do not express a preference for an in office procedure
- •At-risk for unintended pregnancy defined as:
- •those who report being sexually active (vaginal sex with partners with sperm)
- •have not been told by a clinician that they cannot become pregnant
- •have not had a permanent contraception procedure and whose current sexual partner(s) has not had a permanent contraception procedure
- •who are not using a long-acting reversible contraceptive (LARC)
- •Willing and able to provide informed consent
- •Willing/able to receive phone calls from study staff and complete electronic surveys distributed by EMR or email
- •Planning to live within the state of Oregon or Washington for the 12 month study period.
排除标准
- •Less than 18 and older than 40 years old at the time of consent
- •Any medical contraindications to MAB (hemorrhagic disorder or will be taking anticoagulants during study period, chronic adrenal failure or will be taking long term corticosteroids >1 week during study period, inherited porphyria, or an allergy to mifepristone or misoprostol)
- •Currently pregnant or desiring pregnancy in the next year
- •State they would not seek to end a pregnancy if they became pregnant in the next year or who express a preference for an in office procedure
- •History of ectopic pregnancy
结局指标
主要结局
The proportion of participants reporting confidence in key steps of taking medications
时间窗: Enrollment to 12 months
The proportion of participants reporting confidence in key steps of taking medications in follow-up surveys
Proportion of participants reporting satisfaction with the process
时间窗: Enrollment to 12 months
Proportion of participants reporting satisfaction with the process in follow up surveys
次要结局
未报告次要终点
研究者
Alison Edelman
Clinical Instructor
Oregon Health and Science University